Ventral Hernia Treatment Market Report 2026

Ventral Hernia Treatment Market Overview

• Ventral Hernia Treatment market size has reached to $5.22 billion in 2025 • Expected to grow to $7.3 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Impact Of Rising Obesity Rates On The Growth Of The Ventral Hernia Treatment Market • Market Trend: Technological Advancements In Hernia Treatment With Laparoscopic And Open Hernia Mesh Fixation Devices • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Ventral Hernia Treatment Market?

Ventral hernia treatment refers to the medical procedures and interventions used to repair hernias that occur in the abdominal wall. It typically involves the use of robotic-assisted surgery, tension-free mesh repair, and laparoscopic intraperitoneal. The treatment aims to reposition displaced tissues, strengthen the abdominal wall, and prevent recurrence. These treatments are used to relieve pain, restore normal function, and reduce the risk of complications such as bowel obstruction or strangulation. The main types of ventral hernia treatment are epigastric (stomach area) hernia, umbilical (belly button) hernia, and incisional hernia. An epigastric hernia occurs when fatty tissue pushes through a weakened area in the upper part of the abdominal wall, between the sternum and the belly button. It can be diagnosed using ultrasound, computed tomography (ct) scan, and magnetic resonance imaging (mri) and offers various types of surgeries such as open hernia surgery, laparoscopic surgery, and robotic hernia surgery. It is used by hospitals, ambulatory surgical centres, and clinics.

What Is The Ventral Hernia Treatment Market Growth Forecast?

The ventral hernia treatment market size is expected to see strong growth in the next few years. It will grow to $7.3 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing adoption of robotic surgery platforms, growing demand for tension-free repair techniques, expansion of ambulatory surgical centers, rising focus on reducing hernia recurrence rates, increasing investments in advanced surgical technologies. Major trends in the forecast period include increasing adoption of robotic-assisted hernia repair, rising use of advanced hernia mesh materials, growing preference for minimally invasive procedures, expansion of day-care surgical treatments, improved post-surgical recovery protocols.

Global Ventral Hernia Treatment Market Segmentation

1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia 2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI) 3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery 4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics Subsegments: 1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia 2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia 3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia

What Is The Driver Of The Ventral Hernia Treatment Market?

Increasing prevalence of obesity is expected to propel the growth of the ventral hernia treatment market going forward. Obesity is a medical condition characterized by an excessive amount of body fat that significantly impacts an individual's health. Increasing prevalence of obesity is due to poor diet, sedentary lifestyle, genetic factors, lack of physical activity, environmental influences, and emotional stress. Ventral hernia treatment supports obesity patients by addressing the complications that arise from excessive weight, as it helps alleviate strain on the abdominal wall, reduces the risk of hernia recurrence, and enhances overall abdominal strength, which is essential for promoting mobility and encouraging healthier lifestyle choices in individuals struggling with obesity. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that approximately one in eight people worldwide were struggling with obesity. This included 2.5 billion adults (aged 18 years and older) who were overweight, with 890 million of them living with obesity. Among adults, 43% were overweight, and 16% were classified as obese. Additionally, the number of overweight children under the age of 5 reached 37 million. Therefore, increasing prevalence of obesity drives the ventral hernia treatment industry.

Key Players In The Global Ventral Hernia Treatment Market

Major companies operating in the ventral hernia treatment market are Johnson & Johnson Services Inc., Medtronic Plc, Becton, Dickinson and Company (BD), Braun Melsungen AG, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc, KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd

Global Ventral Hernia Treatment Market Trends and Insights

Major companies operating in the ventral hernia treatment market are focusing on technological advancements, such as laparoscopic and open hernia mesh fixation devices, to improve surgical outcomes, reduce complications, and enhance patient recovery. Laparoscopic and open hernia mesh fixation devices refer to medical tools used to secure mesh during hernia repair surgeries, either through minimally invasive (laparoscopic) or traditional open surgical approaches. For instance, in March 2024, TELA Bio Inc., a US-based medical technology company, launched the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices in the U.S. LIQUIFIX FIX8 is for minimally invasive repairs, while LIQUIFIX precision is for open femoral and inguinal hernia repairs. These FDA-approved devices use liquid anchors to affix mesh without penetrating tissue, reducing trauma and complications. With over 1.2 million hernia procedures annually in the U.S., LIQUIFIX offers precision and safety in sensitive areas and minimizes vascular or nerve injury risks.

What Are Latest Mergers And Acquisitions In The Ventral Hernia Treatment Market?

In August 2023, Steris plc, an Ireland-based medical device company, acquired surgical instrumentation assets from Becton, Dickinson, and Company for an undisclosed amount. With this acquisition, Steris plc expands its portfolio in the surgical instrumentation market by acquiring advanced tools and technologies previously owned by Becton, Dickinson, and Company, enhancing its ability to provide comprehensive solutions for hospitals and surgical centers, while strengthening its position in the medical device industry and further supporting its growth in the global healthcare market. Becton, Dickinson, and Company is a US-based medical technology company that provides ventral hernia treatment options.

Regional Outlook

North America was the largest region in the ventral hernia treatment market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ventral Hernia Treatment Market?

The ventral hernia treatment market consists of revenues earned by entities by providing services such as surgical consultations, hernia repair surgeries, post-operative care, diagnostic imaging and others. The market value includes the value of related goods sold by the service provider or included within the service offering. The ventral hernia treatment market also includes sales of fixation devices, surgical instruments, wound care products, surgical sutures and staplers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ventral Hernia Treatment Market Report 2026?

The ventral hernia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ventral hernia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.